Related Experiment Video
Updated: May 11, 2026
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Primary Sclerosing Cholangitis: Current and Future Management Strategies
John E Eaton1, Jayant A Talwalkar
1Cholestatic Liver Diseases Study Group, Department of Gastroenterology and Hepatology, Mayo Clinic College of Medicine.
Current Hepatitis Reports
|May 18, 2013
Summary
Primary sclerosing cholangitis (PSC) is a chronic liver disease with unknown causes and no cures. This review covers PSC
Area of Science:
- Hepatology
- Gastroenterology
- Autoimmune Diseases
Background:
- Primary sclerosing cholangitis (PSC) is a rare, chronic cholestatic liver disease of unknown etiology.
- It is frequently associated with inflammatory bowel disease (IBD).
- PSC significantly increases the risk of developing hepatobiliary and colorectal cancers.
Purpose of the Study:
- To review the clinical presentation and diagnostic methods for PSC.
- To discuss comorbidities associated with PSC.
- To outline screening protocols for PSC-related malignancies and explore current and future therapeutic strategies.
Main Methods:
- Literature review of clinical features, diagnostics, and management of PSC.
- Analysis of screening strategies for associated malignancies.
- Evaluation of existing and emerging treatment options.
Main Results:
- PSC diagnosis relies on clinical, biochemical, and imaging findings.
- Associated conditions include IBD, pancreatitis, and osteoporosis.
- Surveillance for cholangiocarcinoma and colorectal cancer is crucial.
Conclusions:
- PSC management requires a multidisciplinary approach.
- Early diagnosis and vigilant screening are key to improving outcomes.
- Ongoing research aims to identify effective therapies for PSC.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:23Gastritis III: Clinical Manifestations and Management
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...